4Liebowitz LD, Slabbert M, Huisamen A. National surveillance pro- gramme on susceptibility patterns of respiratory pathogens in south Africa:moxifloxacin compare -d with eight other antimicrobial a- gents [ J ]. j Clin Patho1,2003,56 (5) : 344 - 347.
3Denning DW,Munoz P. Advances in invasive fungal infection and antifungal terapy : Introduction. Clin Microbiol Infect ,2001,7 Suppl 2:6.
4Ely EW, Peacock JE Jr, Haponik EF, et al. Cryptococcal pneumonia complicating pregnancy. Medicine (Baltimore), 1998, 77:153-167.
5Bechsague C. Trends in epidemiology of nosocomial fungal infection in the United States section in acute leukemia. Chin Microbiol Infect, 1994, 8:363.
6Mitctll TG, erfect JR. Cryptocococcosis in the era of AIDS100 years after the discovery of Cryptococcus neofomans. Clin Microbiol, 1995, 8:515.
7Fry D.The economic costs of surgical site infection[J].Surgical Infections,2002,3 (Suppl) L:S37.
8Kallen A,Driscoll TJ,Thornton S,et al.Increase in community acquired methicillin resistant staphylococcus aureus at a naval medical center[J].Infect Control Hosp Epidemiol,2000,21:223-226.
